0.5 ML respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML Prefilled Syringe [Mresvia]
RxNorm concept 2685012, branded drug (sbd). Prescribable name: mRESVIA 50 MCG in 0.5 ML Prefilled Syringe.
- RxCUI
- 2685012
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2685012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.5 ML Mresvia 0.1 MG/ML Prefilled Syringe; mRESVIA 50 MCG per 0.5 ML Prefilled Syringe
Related concepts
- respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML (SCDC, consists of)
- respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML [Mresvia] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Mresvia (BN, has ingredient)
- 0.5 ML respiratory syncytial virus pre-fusion F glycoprotein mRNA 0.1 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2685012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2685012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2685012. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.